The cytolytic activity (CYT) score is a new index of cancer immunity calculated from the mRNA expression levels of GZMA and PRF1; we concluded that the HCC patients with higher ICRPI had lower CYT scores compared to those observed in lower ICRPI patients (p < 0.01, Figure 4L). The gene discussed is PRF1; the disease is hepatocellular carcinoma.